OC13 is an educational event open to anyone looking to obtain insight into the OpenClinica clinical trial software platform, learn useful new skills, and build relationships within the vibrant OpenClinica community. This year’s event features best practices, case studies, demos, and hands-on activities. View the conference program to choose from a list of valuable sessions such as: “Utilizing CDISC Standards to Drive Efficiencies in Study Set-up and Build,” and “The Changing Face of Clinical Trials – Patient-Centered Research,” to a sneak peak at exciting future developments for OpenClinica.
Attendees can also choose to participate in a set of hands-on workshops and training classes. These workshops deliver highly-relevant information on key subjects such as regulatory compliance and validation, web services and integration, edit checks and rules, and moving from paper to electronic data capture (EDC). For a more thorough understanding of OpenClinica, you can take full “Central User” or “Developer” training on this robust platform.
Kicking-off the conference as keynote speaker is Douglas Bain, a recognized veteran in the eclinical industry who has worked in a leadership role with many prominent clinical research technology leaders. In his address, Mr. Bain will focus on the emerging dynamics of patient-centered clinical trials.
“I am thrilled to deliver the keynote at this year’s OpenClinica conference,” said Mr. Bain. “Clinical research modalities are changing, and I look forward to sharing my insights into where things are headed with such an innovative community.”
Conference attendees are invited aboard the Odyssey for a dinner cruise and unique views of the city from Boston Harbor.
Also in Boston, immediately following OC13, is the 49th DIA Annual Meeting, June 23-27 at the Boston Convention and Exhibition Center.
OpenClinica is the leading open source clinical trials software platform, and increases the quality and pace of clinical research worldwide. With a global community of users and thousands of implementations, OpenClinica presents a compelling way to obtain greater value in clinical trials. The OpenClinica software is backed by Waltham, Massachusetts-based OpenClinica, LLC, who provides commercial grade support for the open source platform. For more information – including product downloads – visit http://www.openclinica.com or follow @OpenClinica on Twitter.